UPDATES

$Virpax Pharmaceuticals (VRPX.US)$ On December 17, 2024, Virpax Pharmaceuticals appointed Jaydriane (Jay) Panis to its Board of Directors, filling the vacancy left by Gary Herman's resignation. Panis, a Certified Financial Planner with over 20 years of experience, is the founder of his own financial planning practice and serves as a director at a prominent Canadian financial planning firm in British Columbia.Panis brings expertise in financial management and business management to the Board. The company believes his leadership experience and strategic insights will be valuable assets. There are no special arrangements or related transactions associated with Panis's appointment that require disclosure under SEC regulations.The appointment was reported in an SEC Form 8-K filed on December 18, 2024, demonstrating Virpax's commitment to strengthening its financial oversight and strategic planning capabilities.